cysteine has been researched along with Leukemia L 1210 in 29 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 24 (82.76) | 18.7374 |
1990's | 5 (17.24) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Burba-Anczewska, I; Danysz, A; Pniewska, A; Pragłowski, T; Wierzba, K; Wutkiewicz, M | 1 |
Baskin, SI; Besa, EC; Joseph, RR; Knight, T | 1 |
Fan, CC; Huennekens, FM; Vitols, KS | 1 |
Brodie, AE; Potter, J; Reed, DJ | 1 |
Bannai, S; Hishinuma, I; Ishii, T; Sugita, Y | 1 |
Bannai, S; Ishii, T; Sugita, Y | 1 |
Blankenship, DT; Freisheim, JH; Kaufman, BT; Kumar, AA | 1 |
Fisher, JM; Rabinovitz, M; Uehara, Y | 1 |
Fontecave, M; Henry, Y; Lepoivre, M; Roy, B | 1 |
Bartoli, MH; Benoit-Guyod, JL; Krivobok, S; Seigle-Murandi, F; Steiman, R | 1 |
Chaykovsky, M; Ragin, R; Uren, JR | 1 |
Cline, MJ; Toohey, JI | 1 |
Harrap, KR; Jackson, RC; Taylor, GA | 1 |
Frank, N; Osswald, H | 1 |
Francetic, DJ; Roberts, JC | 1 |
Francetic, DJ; Roberts, JC; Zera, RT | 1 |
Akman, SA; Block, JS; Chlebowski, RT; Dietrich, MF; Doroshow, JH | 1 |
Ahmad, S; Aljian, J; Okine, L; Vistica, DT; Wood, R | 1 |
Akman, SA; Block, JB; Chlebowski, R; Dietrich, M; Limberg, P | 1 |
Schwieder, G; Wagner, T; Zink, M | 1 |
Ahmad, S; Le, B; Najarian, P; Okine, L; Vistica, DT | 1 |
Toohey, JI | 1 |
Ishii, T; Sugita, Y; Takada, A; Todoroki, T | 1 |
Fisher, JM; Mohindru, A; Rabinovitz, M | 1 |
Bannai, S; Ishii, T | 1 |
Broome, JD; Jeng, MW | 2 |
Cheng, CC; Zee-Cheng, KY | 2 |
29 other study(ies) available for cysteine and Leukemia L 1210
Article | Year |
---|---|
Influence of some sulfhydryl compounds on the antineoplastic effectiveness of 5-fluorouracil and 6-mercaptopurine.
Topics: Animals; Cysteine; Drug Synergism; Fluorouracil; Glutathione; Insulin; Leukemia L1210; Mercaptopurine; Mice; Mice, Inbred DBA; Neoplasms, Experimental; Sarcoma 180; Sulfhydryl Compounds | 1984 |
Effect of intermittent and continuous administration of L-cysteine hydrochloride on L1210 mouse leukemia.
Topics: Animals; Cysteine; Drug Administration Schedule; Female; Leukemia L1210; Mice; Mice, Inbred DBA | 1983 |
Inhibition of dihydrofolate reductase by methotrexate: a new look at an old problem.
Topics: Animals; Catalysis; Cells, Cultured; Cysteine; Folic Acid Antagonists; Histidine; Kinetics; Leukemia L1210; Methotrexate; Mice; NADP; Structure-Activity Relationship | 1980 |
Unique characteristics of rat spleen lymphocyte, L1210 lymphoma and HeLa cells in glutathione biosynthesis from sulfur-containing amino acids.
Topics: Amino Acids, Sulfur; Animals; Cell-Free System; Cysteine; Glutathione; HeLa Cells; Humans; In Vitro Techniques; Leukemia L1210; Lymphocytes; Lymphoma; Male; Rats; Spleen | 1982 |
Mechanism of growth promotion of mouse lymphoma L1210 cells in vitro by feeder layer or 2-mercaptoethanol.
Topics: Animals; Cell Division; Culture Media; Cysteine; Cystine; Glutathione; Leukemia L1210; Lymphoma; Mercaptoethanol; Mice | 1981 |
Mechanism of growth stimulation of L1210 cells by 2-mercaptoethanol in vitro. Role of the mixed disulfide of 2-mercaptoethanol and cysteine.
Topics: Amino Acids; Animals; Cell Division; Cysteine; Disulfides; Glutathione; Kinetics; Leukemia L1210; Mercaptoethanol; Mice | 1981 |
Activation of bovine and chicken liver dihydrofolate reductases and its relationship to a specific cysteine residue in their NH2-terminal amino acid sequences.
Topics: Amino Acid Sequence; Animals; Bacteria; Cattle; Chickens; Cysteine; Enzyme Activation; Hydroxymercuribenzoates; Iodoacetates; Kinetics; Leukemia L1210; Liver; Mice; Protein Binding; Sarcoma 180; Species Specificity; Swine; Tetrahydrofolate Dehydrogenase | 1980 |
Showdomycin and its reactive moiety, maleimide. A comparison in selective toxicity and mechanism of action in vitro.
Topics: Adenosine; Animals; Antibiotics, Antineoplastic; Biological Transport; Cell Line; Cysteine; Leukemia L1210; Male; Maleimides; Mice; Nucleosides; Showdomycin | 1980 |
Inhibition of ribonucleotide reductase by nitric oxide derived from thionitrites: reversible modifications of both subunits.
Topics: Adenocarcinoma; Animals; Cell Line; Cysteine; Electron Spin Resonance Spectroscopy; Escherichia coli; Free Radicals; Kinetics; Leukemia L1210; Macromolecular Substances; Mice; Nitric Oxide; Nitrites; Ribonucleotide Reductases; Spectrophotometry; Tumor Cells, Cultured; Tyrosine | 1995 |
Antitumoral activity of patulin and patulin-cysteine adducts.
Topics: Animals; Antineoplastic Agents, Phytogenic; Cysteine; Female; Leukemia L1210; Leukemia P388; Mice; Mice, Inbred Strains; Mitomycin; Patulin | 1994 |
Modulation of cysteine metabolism in mice--effects of propargylglycine and L-cyst(e)ine-degrading enzymes.
Topics: Alkynes; Animals; Cystathionine gamma-Lyase; Cysteine; Diet; Enterobacter; Glycine; Half-Life; In Vitro Techniques; Kinetics; Leukemia L1210; Liver; Lyases; Mice; Rats | 1978 |
Alkylthiolation. Evidence for involvement in cell division.
Topics: Animals; Cell Division; Cell Line; Cysteine; Disulfides; Dithiothreitol; Glutathione; Kinetics; Leukemia L1210; Mice; Structure-Activity Relationship; Sulfhydryl Compounds | 1976 |
The reaction of Cytembena with cellular thiol compounds.
Topics: Acrylates; Animals; Cells, Cultured; Cysteine; Glutathione; Inactivation, Metabolic; Leukemia L1210; Mice; Sarcoma, Yoshida; Sulfhydryl Compounds | 1976 |
Sacrosine- and prolinedithiocarbamate pretreatment increases the therapeutic efficacy of doxorubicin, methotrexate, teniposide, mitoxantrone or cyclohexylchloroethylnitrosourea in leukemia L1210.
Topics: Animals; Antineoplastic Agents; Cysteine; Doxorubicin; Drug Synergism; Female; Leukemia L1210; Lomustine; Methotrexate; Mice; Mice, Inbred DBA; Mitoxantrone; Proline; Sarcosine; Teniposide; Thiocarbamates | 1990 |
Time course for the elevation of glutathione in numerous organs of L1210-bearing CDF1 mice given the L-cysteine prodrug, RibCys.
Topics: Animals; Cysteine; Glutathione; Injections, Intraperitoneal; Leukemia L1210; Liver; Male; Mice; Prodrugs; Thiazoles; Thiazolidines | 1991 |
L-cysteine prodrug protects against cyclophosphamide urotoxicity without compromising therapeutic activity.
Topics: Animals; Cyclophosphamide; Cysteine; Dose-Response Relationship, Drug; Drug Interactions; Drug Screening Assays, Antitumor; Glutathione; Leukemia L1210; Male; Mice; Mice, Inbred Strains; Neoplasm Transplantation; Prodrugs; Thiazoles; Thiazolidines; Time Factors; Urinary Bladder | 1991 |
Synergistic cytotoxicity between menadione and dicumarol vs. murine leukemia L1210.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Combined Chemotherapy Protocols; Calcium; Cell Division; Cysteine; Dicumarol; Drug Synergism; Glutathione; Leukemia L1210; Mice; NADP; Oxidation-Reduction; Oxygen Consumption; Quinones; Vitamin K | 1987 |
gamma-Glutamyl transpeptidase (gamma-GT) and maintenance of thiol pools in tumor cells resistant to alkylating agents.
Topics: Alkylating Agents; Animals; Cell Line; Cysteine; Drug Resistance; Ethylmaleimide; gamma-Glutamyltransferase; Glutamates; Kinetics; Leukemia L1210; Melphalan; Mice; Sulfhydryl Compounds | 1987 |
Modulation of cytotoxicity of menadione sodium bisulfite versus leukemia L1210 by the acid-soluble thiol pool.
Topics: Animals; Cysteine; Dose-Response Relationship, Drug; Glutathione; Kinetics; Leukemia L1210; Mice; NADP; Oxidation-Reduction; Superoxides; Vitamin K; Vitamin K 3 | 1985 |
Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
Topics: Animals; Cyclophosphamide; Cysteine; Drug Interactions; Female; Leukemia L1210; Mercaptoethanol; Mesna; Metabolic Clearance Rate; Mice; Platelet Count; Sulfhydryl Compounds | 1987 |
Elevation of glutathione in phenylalanine mustard-resistant murine L1210 leukemia cells.
Topics: Animals; Cysteine; Dipeptides; Drug Resistance; Glutathione; Glutathione Disulfide; Kinetics; Leukemia L1210; Melphalan; Mice | 1987 |
Persulfide sulfur is a growth factor for cells defective in sulfur metabolism.
Topics: Albumins; Animals; Cell Division; Cell Line; Cystamine; Cysteamine; Cysteine; Disulfides; Globulins; Growth Substances; Leukemia L1210; Mercaptoethanol; Mice; Serum Albumin, Bovine; Sulfhydryl Compounds | 1986 |
Mouse lymphoma L1210 cells can be arrested in the G1 phase by adjusting cellular cysteine and glutathione.
Topics: Animals; Cell Cycle; Cells, Cultured; Cysteine; Glutathione; Interphase; Leukemia L1210; Mercaptoethanol; Mice; Nucleic Acids; Protein Biosynthesis | 1985 |
Endogenous copper is cytotoxic to a lymphoma in primary culture which requires thiols for growth.
Topics: Animals; Cell Division; Chelating Agents; Copper; Cysteine; Leukemia L1210; Mice; Oxidation-Reduction; Phenanthrolines; Sulfhydryl Compounds | 1985 |
The synergistic action of the copper chelator bathocuproine sulphonate and cysteine in enhancing growth of L1210 cells in vitro.
Topics: Animals; Blood; Cell Count; Cell Division; Cysteine; Drug Synergism; Leukemia L1210; Mercaptoethanol; Mice; Phenanthrolines; Sulfhydryl Compounds | 1985 |
Growth stimulation of mouse leukemia cells by thiols and disulfides in vitro.
Topics: Animals; Cysteamine; Cysteine; Disulfides; In Vitro Techniques; Leukemia L1210; Lymphoma; Mercaptoethanol; Neoplasms, Experimental | 1972 |
Promotion of replication in lymphoid cells by specific thiols and disulfides in vitro. Effects on mouse lymphoma cells in comparison with splenic lymphocytes.
Topics: Animals; Cell Line; Cells, Cultured; Cysteine; Disulfides; Half-Life; Leukemia L1210; Lymphocytes; Lymphoma; Mercaptoethanol; Mice; Mitogens; Mitosis; Spleen; Structure-Activity Relationship; Sulfhydryl Compounds; Thymidine | 1973 |
Structural modification of S-trityl-L-cysteine. Preparation of some S-(substituted trityl)-L-cysteines and dipeptides of S-trityl-L-cysteine.
Topics: Animals; Antineoplastic Agents; Cysteine; Dipeptides; Leukemia L1210; Mice; Structure-Activity Relationship | 1972 |
Experimental antileukemic agents. Preparation and structure-activity study of S-tritylcysteine and related compounds.
Topics: Animals; Antineoplastic Agents; Cysteine; Leukemia L1210 | 1970 |